REQUEST A DEMO
Total
USD $0.00
Search more companies

Gold Medic Centro De Diagnostico Y Tratamiento Ips Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Gold Medic Centro De Diagnostico Y Tratamiento Ips Sas Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Gold Medic Centro De Diagnostico Y Tratamiento Ips Sas is a company in Colombia, with a head office in Sabana de Torres. It operates in the Ambulatory Health Care Services industry. It was established on November 13, 2019. From the latest financial highlights, Gold Medic Centro De Diagnostico Y Tratamiento Ips Sas reported a net sales revenue increase of 17.74% in 2025. Its’ total assets recorded a growth of 163.51%. In, 2025, the company’s net profit margin increased by 13.41%.

Headquarters
Cr 9 14 123
Sabana de Torres; Santander;

Contact Details: Purchase the Gold Medic Centro De Diagnostico Y Tratamiento Ips Sas report to view the information.

Basic Information
Registered Capital:
Purchase the Gold Medic Centro De Diagnostico Y Tratamiento Ips Sas report to view the information.
Financial Auditors:
Purchase the Gold Medic Centro De Diagnostico Y Tratamiento Ips Sas report to view the information.
Incorporation Date:
November 13, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Gold Medic Centro De Diagnostico Y Tratamiento Ips Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
17.74%
Total Operating Revenue
17.74%
Operating Profit
221.66%
EBITDA
237.18%
Net Profit/Loss for the Period
3230.53%
Total Assets
163.51%
Total Equity
N/A
Operating Profit Margin
12.37%
Net Profit Margin
13.41%
Return on Equity (ROE)
N/A
Debt / Equity
N/A
Quick Ratio
0.3%
Cash Ratio
0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?